AnteoTech (ASX:ADO) received an order from the Serum Institute of India for $185,000 on Dec. 24, in line with the five-year supply agreement between the parties, according to a Monday Australian bourse filing.
The order will be dispatched on Jan. 5, 2026. It will also provide prototypes of a new AnteoBind activated enzyme-linked immunosorbent assay plate product, currently under development, to the Serum Institute of India.
It also secured new sales to Japanese customers of around AU$70,000, and it is working on the appointment of a new distributor in Japan.
Its shares jumped 12% in recent trading on Monday.